Symptom clusters and quality of life in survivors of lung cancer

被引:106
|
作者
Fox, Sherry W. [1 ]
Lyon, Debra E.
机构
[1] Univ Virginia, Sch Nursing, Charlottesville, VA 22903 USA
[2] Virginia Commonwealth Univ, Sch Nursing, Richmond, VA 23284 USA
关键词
D O I
10.1188/06.ONF.931-936
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose/Objectives: To explore the prevalence and intensity of depression, fatigue, and pain in survivors of lung cancer; to examine the relationship of symptoms in a cluster; and to examine the relationship of the symptom cluster to quality of life (QOL). Design: Secondary data analysis. Setting: Online lung cancer support group. Sample: 51 patients diagnosed with lung cancer. Methods: Mailed survey with self-report of depression, fatigue, and pain measured by subscales of the Short-Form 36 Health Status Survey and QOL measured by the Fox Simple QOL Scale. Pearson's correlation and multiple regression analyses were used to examine the possible symptom cluster. Main Research Variables: Depression, fatigue, pain, and QOL. Findings: Depression, fatigue, and pain were found in a majority of survivors, with pain being the least common symptom. Fatigue was the most intense of the three symptoms, Two significantly correlated symptoms were depression and fatigue. The cluster explained 29% (p < 0.01) of the variance in QOL in the lung cancer survivors. Conclusions: The data provided preliminary support for the presence of a symptom cluster in patients with lung cancer consisting of depression and fatigue. The cluster had a negative relationship with QOL. Survivors of lung cancer have depression and fatigue that affect QOL. Implications for Nursing: Healthcare providers must assess the potential for symptoms to cluster, adversely affecting key patient outcomes such as QOL. Through increased knowledge of symptom clusters, clinicians will be able to more effectively target the most distressing set of symptoms for intervention.
引用
收藏
页码:931 / 936
页数:6
相关论文
共 50 条
  • [21] Symptom clusters in Latina breast cancer survivors
    Crane, Tracy
    PSYCHO-ONCOLOGY, 2017, 26 : 16 - 16
  • [22] EXPLORING SYMPTOM CLUSTERS IN PROSTATE CANCER SURVIVORS
    Lee, Lena
    Ross, Alyson
    Saligan, Leorey
    Ding, Ya
    Wallen, Gwenyth
    ONCOLOGY NURSING FORUM, 2020, 47 (02)
  • [23] Trends and predictors of Quality of Life in lung cancer survivors
    Bade, Brett C.
    Zhao, Julian
    Li, Fangyong
    Tanoue, Lynn
    Lazowski, Heather
    Alfano, Catherine M.
    Silvestri, Gerard A.
    Irwin, Melinda L.
    LUNG CANCER, 2024, 191
  • [24] Sleep and quality of life in lung cancer patients and survivors
    Martin, Rachel E.
    Loomis, Dianne M.
    Dean, Grace E.
    JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2022, 34 (02) : 284 - 291
  • [25] Survivors of lung cancer have good quality of life
    Boughton, B
    LANCET ONCOLOGY, 2002, 3 (09): : 522 - 522
  • [26] Relationship Between Cytokine Gene Single Nucleotide Polymorphisms and Symptom Burden and Quality of Life in Lung Cancer Survivors
    Rausch, Sarah M.
    Clark, Matthew M.
    Patten, Christi
    Liu, Heshan
    Felten, Sara
    Li, Yafei
    Sloan, Jeff
    Yang, Ping
    CANCER, 2010, 116 (17) : 4103 - 4113
  • [27] SYMPTOM CLUSTERS IN LUNG CANCER PATIENTS
    Xu, Yangmu
    Owen, Jason E.
    Thornton, Andrea
    Stanton, Annette L.
    ANNALS OF BEHAVIORAL MEDICINE, 2013, 45 : S199 - S199
  • [28] Identifying Symptom Clusters in Breast Cancer: Implications on Patient Quality of Life
    Lis, C. G.
    Birdsall, T. C.
    Stark, J. J.
    Cain, L.
    Campbell, K.
    Gilbert, K.
    Gupta, D.
    CANCER RESEARCH, 2009, 69 (24) : 779S - 779S
  • [29] Symptom Clusters and Quality of Life in Gastric Cancer Patients Receiving Chemotherapy
    Fu, Liang
    Feng, Xiuqin
    Jin, Yongyan
    Lu, Zhenqi
    Li, Rufang
    Xu, Wenxia
    Chang, Victor T.
    Hu, Yan
    Ye, Xianghong
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2022, 63 (02) : 230 - 243
  • [30] Symptom Experiences and Symptom Clusters in Advanced Lung Cancer
    Popat, S.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1640 - S1641